Oct 03, 2011, 05.43 PM IST
Pharma major Wockhardt now has additional time on its hands to finalise a formal repayment plan for its overseas bond holders.
The company has total dues of Rs 358 crore it was supposed to revert to the Bombay High Court with a detailed plan by October 3.
It now has extra time as the court today adjourned the case to October 11.
A group of bondholders led by the bond trustee of the Bank of New York Mellon, Sun Pharma Global and hedge fund QVT besides some creditors had taken Wockhardt to court, filing a wind-up petition, after the company defaulted on repayment of its USD 110-million FCCBs, in 2009.
Wockhardt stock price
On December 09, 2013, at 12:27 hrs Wockhardt was quoting at Rs 401.50, up Rs 0.85, or 0.21 percent. The 52-week high of the share was Rs 2166.05 and the 52-week low was Rs 344.15.
The company's trailing 12-month (TTM) EPS was at Rs 32.23 per share as per the quarter ended September 2013. The stock's price-to-earnings (P/E) ratio was 12.46. The latest book value of the company is Rs 74.56 per share. At current value, the price-to-book value of the company is 5.38.
Action in Wockhardt
Video of the day
Dec 6 2013, 15:02
- in MARKET OUTLOOK
Dec 4 2013, 11:08
- in FII View
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.